Response and Resistance to Trametinib in MAP2K1-Mutant Triple-Negative Melanoma.
Krebs FS, Moura B, Missiaglia E, Aedo-Lopez V, Michielin O, Tsantoulis P, Bisig B, Trimech M, Zoete V, Homicsko K.
Krebs FS, et al. Among authors: trimech m.
Int J Mol Sci. 2023 Feb 24;24(5):4520. doi: 10.3390/ijms24054520.
Int J Mol Sci. 2023.
PMID: 36901951
Free PMC article.